MX9201916A - Derivados de 4-aril-3-hetero aril ureido quinolina como agentes antihipercolesterolemicos y antiaterosclerosicos. - Google Patents
Derivados de 4-aril-3-hetero aril ureido quinolina como agentes antihipercolesterolemicos y antiaterosclerosicos.Info
- Publication number
- MX9201916A MX9201916A MX9201916A MX9201916A MX9201916A MX 9201916 A MX9201916 A MX 9201916A MX 9201916 A MX9201916 A MX 9201916A MX 9201916 A MX9201916 A MX 9201916A MX 9201916 A MX9201916 A MX 9201916A
- Authority
- MX
- Mexico
- Prior art keywords
- aryl
- atherosclerosic
- ureid
- hypercholesterolemic
- quinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69232391A | 1991-04-26 | 1991-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9201916A true MX9201916A (es) | 1992-11-01 |
Family
ID=24780107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9201916A MX9201916A (es) | 1991-04-26 | 1992-04-24 | Derivados de 4-aril-3-hetero aril ureido quinolina como agentes antihipercolesterolemicos y antiaterosclerosicos. |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0590094A1 (pt) |
| JP (1) | JPH0776215B2 (pt) |
| CN (1) | CN1066068A (pt) |
| AU (1) | AU1879792A (pt) |
| BR (1) | BR9205939A (pt) |
| CA (1) | CA2108014A1 (pt) |
| CZ (1) | CZ395592A3 (pt) |
| DE (1) | DE9290049U1 (pt) |
| FI (1) | FI934710A (pt) |
| HU (1) | HUT65748A (pt) |
| IE (1) | IE921330A1 (pt) |
| IL (1) | IL101627A0 (pt) |
| MX (1) | MX9201916A (pt) |
| NO (1) | NO933837L (pt) |
| NZ (1) | NZ242493A (pt) |
| PT (1) | PT100426A (pt) |
| TW (1) | TW197436B (pt) |
| WO (1) | WO1992019614A1 (pt) |
| YU (1) | YU44592A (pt) |
| ZA (1) | ZA922976B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993015058A1 (en) * | 1992-01-23 | 1993-08-05 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| US5565472A (en) * | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| NZ264063A (en) * | 1993-08-13 | 1995-11-27 | Nihon Nohyaku Co Ltd | N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions |
| US5843957A (en) * | 1995-05-19 | 1998-12-01 | Sumitomo Pharmaceuticals Company, Ltd. | Naphthyridine derivatives |
| KR100399798B1 (ko) * | 1995-05-31 | 2004-05-31 | 스미또모 세이야꾸 가부시키가이샤 | 신규나프티리딘유도체 |
| CN1245500A (zh) * | 1996-11-26 | 2000-02-23 | 住友制药株式会社 | 新型萘啶衍生物 |
| US6452008B2 (en) | 1998-02-25 | 2002-09-17 | Sumitomo Pharmaceuticals Company, Limited | Pyridone derivatives and process for preparing the same |
| EP1086948A4 (en) | 1998-02-25 | 2004-03-10 | Sumitomo Pharma | PYRIDONE DERIVATIVES AND THEIR MANUFACTURING PROCESS |
| AU2004298486A1 (en) | 2003-12-12 | 2005-06-30 | Wyeth | Quinolines useful in treating cardiovascular disease |
| CN103601677B (zh) * | 2013-11-19 | 2015-11-18 | 清华大学 | 制备2-烷硫基喹啉衍生物的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE892088L (en) * | 1988-07-12 | 1990-01-12 | William Henry Deryk Morris | Quinoline derivatives, their production and use |
| WO1991004027A1 (en) * | 1989-09-15 | 1991-04-04 | Pfizer Inc. | New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
| TW205037B (pt) * | 1989-10-06 | 1993-05-01 | Takeda Pharm Industry Co Ltd |
-
1992
- 1992-03-16 CA CA002108014A patent/CA2108014A1/en not_active Abandoned
- 1992-03-16 DE DE9290049U patent/DE9290049U1/de not_active Expired - Lifetime
- 1992-03-16 WO PCT/US1992/001801 patent/WO1992019614A1/en not_active Application Discontinuation
- 1992-03-16 JP JP4510186A patent/JPH0776215B2/ja not_active Expired - Lifetime
- 1992-03-16 CZ CS923955A patent/CZ395592A3/cs unknown
- 1992-03-16 BR BR9205939A patent/BR9205939A/pt not_active Application Discontinuation
- 1992-03-16 HU HU9303025A patent/HUT65748A/hu active IP Right Revival
- 1992-03-16 EP EP92923349A patent/EP0590094A1/en not_active Withdrawn
- 1992-03-16 AU AU18797/92A patent/AU1879792A/en not_active Abandoned
- 1992-03-17 TW TW081102005A patent/TW197436B/zh active
- 1992-03-24 ZA ZA922976A patent/ZA922976B/xx unknown
- 1992-04-16 IL IL101627A patent/IL101627A0/xx unknown
- 1992-04-24 NZ NZ242493A patent/NZ242493A/en unknown
- 1992-04-24 MX MX9201916A patent/MX9201916A/es not_active IP Right Cessation
- 1992-04-24 YU YU44592A patent/YU44592A/sh unknown
- 1992-04-24 IE IE133092A patent/IE921330A1/en not_active Application Discontinuation
- 1992-04-24 PT PT100426A patent/PT100426A/pt not_active Application Discontinuation
- 1992-04-25 CN CN92103010A patent/CN1066068A/zh active Pending
-
1993
- 1993-10-25 FI FI934710A patent/FI934710A/fi unknown
- 1993-10-25 NO NO933837A patent/NO933837L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1992019614A1 (en) | 1992-11-12 |
| CZ395592A3 (en) | 1994-02-16 |
| AU1879792A (en) | 1992-12-21 |
| FI934710A0 (fi) | 1993-10-25 |
| DE9290049U1 (de) | 1994-01-05 |
| HUT65748A (en) | 1994-07-28 |
| NO933837L (no) | 1993-10-25 |
| NZ242493A (en) | 1994-08-26 |
| BR9205939A (pt) | 1994-09-27 |
| IL101627A0 (en) | 1992-12-30 |
| PT100426A (pt) | 1993-08-31 |
| CA2108014A1 (en) | 1992-10-27 |
| CN1066068A (zh) | 1992-11-11 |
| JPH0776215B2 (ja) | 1995-08-16 |
| EP0590094A1 (en) | 1994-04-06 |
| IE921330A1 (en) | 1992-11-04 |
| YU44592A (sh) | 1994-12-28 |
| HU9303025D0 (en) | 1994-01-28 |
| JPH06501025A (ja) | 1994-01-27 |
| TW197436B (pt) | 1993-01-01 |
| ZA922976B (en) | 1993-10-25 |
| FI934710A (fi) | 1993-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO932176L (no) | Kinolin-, naftyridin- og pyridobenzoksazinderivater | |
| DE59208263D1 (de) | 3-Aryl-4-hydroxy-delta3-dihydrofuranon- und 3-Aryl-4-hydroxy-delta3-dihydrothiophenon-Derivate | |
| DE10299021I2 (de) | Piperazinyl-heterocyclische Derivate | |
| LV10099A (lv) | Bicikliski heterocikliski atvasinajumi | |
| DE69231123T2 (de) | Konjugaten von Zell-bindender Mittel und Derivaten von CC-1065 | |
| ATA75293A (de) | Indolderivate | |
| FR2685328B1 (fr) | Derives de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides. | |
| DE69132519D1 (de) | Quinolin-Derivate | |
| DE69330497D1 (de) | Chinazolin-derivate | |
| MX9201916A (es) | Derivados de 4-aril-3-hetero aril ureido quinolina como agentes antihipercolesterolemicos y antiaterosclerosicos. | |
| DE59308714D1 (de) | Cyclobutan-benzol-derivate | |
| DE69119185D1 (de) | Derivate von Carboxymethyl-Chitin und ihre Verwendung | |
| PL308671A1 (en) | Derivatives of 5-hydrazine quinolone exhibiting anti-microbial activity | |
| MA22916A1 (fr) | Derives de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides. | |
| NO930520D0 (no) | Bifenyl-substituerte kinolinderivater | |
| FR2698359B1 (fr) | Derives de 2-alkoxy 2-imidazoline-5-ones fongicides. | |
| DK0483702T3 (da) | Impulsbredde-moduleret forstærker | |
| NO922934D0 (no) | Cykloheksan- og tetrahydropyranderivater | |
| NO952171D0 (no) | 3-heteroalifatyl- og 3-hetero(aryl)alifatyl-2(1H)-chinolon-derivater | |
| NO952288D0 (no) | Benzazepinon-derivater | |
| DE69313890T2 (de) | 5-Aminoflavon-Derivate | |
| MX9204370A (es) | Derivados de pirazol. | |
| FI912963A0 (fi) | Hjaernverksamheten oekande pyrimidinylderivat. | |
| MX9201635A (es) | Derivados de indol y di hidro quinolina. | |
| BR9106582A (pt) | Derivados de tetrazol e medicamentos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |